Sector ratings Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 46.16 USD | -4.47% |
|
-7.40% | +4.79% |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 09-25 | Scholar Rock Poised for De-risked Commercial Ramp in Neuromuscular Space, Wedbush Says | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 5.88B | - | B | - | - | ||||
| 74.46B | AAA | |||||||
| 60.14B | A | |||||||
| 48.15B | AAA | |||||||
| 44.25B | AAA | |||||||
| 43.99B | - | B | - | - | ||||
| 41.61B | - | |||||||
| 29.97B | A | |||||||
| 29.31B | AAA | |||||||
| 24.93B | - | BBB | - | - | ||||
| 24.69B | - | - | - | - | ||||
| 21.27B | A | |||||||
| 17.42B | BBB | |||||||
| 15.8B | AA | |||||||
| 14.79B | AA | |||||||
| 14.96B | - | - | - | - | ||||
| 14.78B | A | - | ||||||
| 14.47B | BB | |||||||
| 14.83B | AA | |||||||
| 14.08B | AA | |||||||
| Average | 28.49B | AA | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
